A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo

Completed · Phase 3 · Has a placebo group

Conditions studied: Overactive Bladder

In brief

A new drug for overactive bladder is compared to placebo to determine if it is safe and effective. The study lasts approximately 12 weeks.

Key facts

Study ID
NCT00350636
Run by
Watson Pharmaceuticals
People needed
789
Starts
2006-06-01
Expected to finish
2007-05-01
Last updated by the study team
2010-05-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.